Key result
A ferroptosis scoring model based on 60 genes accurately distinguished and predicted survival prognosis and immunotherapy efficacy in breast cancer patients.
Why the study?
Most genes regulating or marking ferroptosis relate to poor cancer prognosis, but their comprehensive relationship with tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer required evaluation.
Observational
A novel ferroptosis scoring model can predict survival prognosis and immunotherapy efficacy in breast cancer patients.
Answers are grounded in this paper and cite their sources.
May support ferroptosis gene profiling for cancer prognosis; leaves open therapeutic relevance pending prospective validation.
Background: Ferroptosis is a kind of programmed cell death that is characterized by iron dependence. It differs from apoptosis, necrosis, autophagy, pyroptosis, and other types of cell death. Some studies have found that most of the genes involved in the regulation of ferroptosis or act as markers of ferroptosis are related to the poor prognosis of cancer patients. Methods: This study evaluated the expression, mutation, and copy number variation (CNV) of 60 previously reported ferroptosis genes in breast cancer samples from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Unsupervised clustering of breast cancer samples with ferroptosis genes was performed, followed by enrichment analysis with Gene Set Variation Analysis (GSVA), mutation display, and correlation analysis of clinical characteristics. Based on the analysis of differences among groups, the ferroptosis-related genes were identified, and the consistent clustering of breast cancer samples was performed. The characteristic genes were screened by stochastic forest algorithm and COX analysis, and a ferroptosis score (ferr.score) model was constructed to evaluate the prognosis of breast cancer patients. Results: Copy number amplification and deletion of ferroptosis genes are common in breast cancer. Breast cancer patients grouped by ferroptosis gene clusters showed significant differences in survival, immune cell infiltration, and enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways. The ferroptosis-related differential genes were identified by comparison among clustering groups of ferroptosis gene. Characteristic genes were screened from these ferroptosis-related differential genes to construct the ferr.score model. The scoring model could accurately distinguish and predict the survival prognosis and immunotherapy efficacy in breast cancer patients. Conclusions: Ferroptosis plays an important role in the occurrence and development of tumors. According to the ferr.score model, the breast cancer samples can be divided into two groups with significantly different prognoses. These results provide novel insights and ideas for immunotherapy in breast cancer patients.
No takes yet. Share an insight, caveat, or question.
He et al. (2022) conducted an observational in Breast cancer. Ferroptosis score (ferr.score) was evaluated on Survival prognosis and immunotherapy efficacy. A ferroptosis scoring model based on 60 genes accurately distinguished and predicted survival prognosis and immunotherapy efficacy in breast cancer patients.
Synapse has enriched 10 related papers. Consider them for comparative context: